V031-1807 Screening compound: 3-(7-ethyl-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propanamide

V031-1807 Screening compound: 3-(7-ethyl-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propanamide
V031-1807 Screening compound: 3-(7-ethyl-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V031-1807
3-(7-ethyl-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V031-1807

Molecular Formula

C26H30F3N3O2 (C26 H30 F3 N3 O2)

Compound Name

3-(7-ethyl-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propanamide

IUPAC name

3-(7-ethyl-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propanamide

SMILES

CCc1cccc2c1[nH]cc2C(CC(NCCN1CCOCC1)=O)c1ccc(C(F)(F)F)cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

473.54

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.350

Distribution Coefficient, logD

4.274

Water Solubility, LogSw

-4.11

Polar Surface Area

46.541

Acid Dissociation Constant (pKa)

12.78

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.30

V031-1807 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Glucocorticoid receptors Library (4806 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Nuclear receptors
  • Kinases
Mechanism of action:
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with V031-1807 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V031-1807?
Check Price and Availability of V031-1807, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V031-1807 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V031-1807
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V031-1807
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V031-1807 available by request